Accelerate novel drug discovery and reduce R&D costs with AI-powered biological data generation.

"Recursion's ability to generate and analyze biological data at an unprecedented scale has been transformative for our early discovery efforts. We're identifying potential drug candidates with greater confidence and at a much faster pace."

"The platform offers a powerful combination of wet lab automation and AI, enabling us to explore complex biological hypotheses more efficiently. While partnership discussions are key, the potential for accelerated discovery is immense."

"Recursion has fundamentally changed how we approach target validation. The speed and depth of insights derived from their integrated platform allow us to move from hypothesis to validated target much more rapidly."

"The predictive capabilities of Recursion's AI are impressive, offering a clearer view into potential compound efficacy and safety profiles. This helps us prioritize resources more effectively in preclinical stages."